Results 101 to 110 of about 260,030 (390)
Kras in metastatic colorectal cancer
Swiss Medical Weekly, 2010 Kras, a small intracellular GTPase, is a central intermediary of the epidermal growth factor receptor (EGFR) and other tyrosine kinase receptor pathways. Increased EGFR and Kras signalling is involved in colorectal carcinogenesis and tumour progression. Mutations of Kras result in the loss of its GTPase activity and thus in a constitutive activation of
Wicki, Andreas +2 more
openaire +5 more sources
mTORC2 signaling drives the development and progression of pancreatic cancer [PDF]
, 2016 mTOR signaling controls several critical cellular functions and is deregulated in many cancers, including pancreatic cancer. To date, most efforts have focused on inhibiting the mTORC1 complex.
Bardeesy, Nabeel +17 more
core +1 more source
Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs
Molecular Oncology, EarlyView.In HGSOC with normal KRAS expression, high PTP4A3 expression regulates autophagy activation. Conversely, in HGSOC with high KRAS expression, KRAS dictates autophagy control, and PTP4A3 is not required. When high PTP4A3 expression is inhibited, HGSOC cells are preferentially sensitised towards DNA‐damaging agents.
Ana López‐Garza +3 more
wiley +1 more source
Brezstropa jama v Podbojevem lazu, Rakov Škocjan
Dela, 2009 Predstavljena je brezstropa jama v Podbojevem lazu, v severozahodnem delu Rakovega Škocjana. Opisane so morfometrične in morfogenetske značilnosti več odsekov brezstrope jame in njene okolice.
Uroš Stepišnik +5 more
doaj +1 more source
Notranjska v pozni bronasti in starejši železni dobi
Arheološki Vestnik, 2021 Prispevek v uvodnem delu prinaša pregled zgodovine raziskav prazgodovinskih najdišč na Notranjskem. V nadaljevanju so predstavljene tri arheološke lokacije, ki dobro zaobjamejo pozno bronasto in starejšo železno dobo notranjske halštatske skupnosti ...
Alma BAVDEK
doaj +1 more source
Molecular Oncology, EarlyView.RKIP, a metastasis suppressor protein, modulates key oncogenic pathways in lung adenocarcinoma. In silico analyses linked low RKIP expression to poor survival. Functional studies revealed RKIP overexpression reduces tumor aggressiveness and enhances sensitivity to EGFR‐targeted therapies, while its loss promotes resistance.
Ana Raquel‐Cunha +10 more
wiley +1 more source
Transcriptome Signature of Immune Cells Post Reovirus Treatment in KRAS Mutated Colorectal Cancer
Cancer Management and Research, 2021 Elisha J Fogel,1 Avishai Samouha,1 Sanjay Goel,2 Radhashree Maitra1,2 1Department of Biology, Yeshiva University, New York, NY, 10033, USA; 2Albert Einstein College of Medicine at Montefiore Medical Center, Bronx, NY, 10461, USACorrespondence: Radhashree
Fogel EJ, Samouha A, Goel S, Maitra R
doaj
Tendence spreminjanja podnebja po 2. svetovni vojni na jugovzhodu Krasa
Dela, 2014 Prispevek obravnava trende spreminjanja temperature zraka in padavin v višjem, jugovzhodnem delu Krasa. Zaledno zmerno sredozemsko podnebje se tu prepleta s celinskim podnebjem, zato se značilnosti spreminjanja podnebja nekoliko razlikujejo od trendov ob
Darko Ogrin
doaj +1 more source
Molecular Oncology, EarlyView.Using multi‐omic characterization, we aimed to identify key regulators specific to squamous cell lung carcinoma (SqCC). SqCC‐specific differentially expressed genes were integrated with metabolics data. High expression of the creatine transporter SLC6A8, along with elevated creatine levels, appeared to be a distinct metabolic feature of SqCC.
Johan Staaf +10 more
wiley +1 more source
EGFR blockade reverts resistance to KRAS G12C inhibition in colorectal cancer.
Cancer Discovery, 2020 Most KRAS G12C mutant non-small cell lung cancer (NSCLC) patients experience clinical benefit from selective KRAS G12C inhibition, while patients with colorectal cancer (CRC) bearing the same mutation rarely respond.
V. Amodio +28 more
semanticscholar +1 more source